These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 21353874)

  • 21. Activin receptors: cellular signalling by receptor serine kinases.
    Zimmerman CM; Mathews LS
    Biochem Soc Symp; 1996; 62():25-38. PubMed ID: 8971337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents.
    Chiu CS; Peekhaus N; Weber H; Adamski S; Murray EM; Zhang HZ; Zhao JZ; Ernst R; Lineberger J; Huang L; Hampton R; Arnold BA; Vitelli S; Hamuro L; Wang WR; Wei N; Dillon GM; Miao J; Alves SE; Glantschnig H; Wang F; Wilkinson HA
    J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1181-92. PubMed ID: 23525481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-finger toxin fold for the extracellular ligand-binding domain of the type II activin receptor serine kinase.
    Greenwald J; Fischer WH; Vale WW; Choe S
    Nat Struct Biol; 1999 Jan; 6(1):18-22. PubMed ID: 9886286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activin type II receptor restoration in ACVR2-deficient colon cancer cells induces transforming growth factor-beta response pathway genes.
    Deacu E; Mori Y; Sato F; Yin J; Olaru A; Sterian A; Xu Y; Wang S; Schulmann K; Berki A; Kan T; Abraham JM; Meltzer SJ
    Cancer Res; 2004 Nov; 64(21):7690-6. PubMed ID: 15520171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High resolution structures of the bone morphogenetic protein type II receptor in two crystal forms: implications for ligand binding.
    Mace PD; Cutfield JF; Cutfield SM
    Biochem Biophys Res Commun; 2006 Dec; 351(4):831-8. PubMed ID: 17094948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activin A and activin receptors in the human thyroid: a link to the female predominance of goiter?
    Schulte KM; Jonas C; Krebs R; Röher HD
    Horm Metab Res; 2000 Oct; 32(10):390-400. PubMed ID: 11069203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An emerging complexity of receptors for transforming growth factor-beta.
    Derynck R; Chen RH; Ebner R; Filvaroff EH; Lawler S
    Princess Takamatsu Symp; 1994; 24():264-75. PubMed ID: 8983081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myostatin blockade therapy for muscular atrophy].
    Sunada Y
    Brain Nerve; 2011 Nov; 63(11):1271-7. PubMed ID: 22068480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular cloning of the Atlantic salmon activin receptor IIB cDNA - Localization of the receptor and myostatin in vivo and in vitro in muscle cells.
    Ostbye TK; Bardal T; Vegusdal A; Frang OT; Kjørsvik E; Andersen O
    Comp Biochem Physiol Part D Genomics Proteomics; 2007 Jun; 2(2):101-11. PubMed ID: 20483283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activins, myostatin and related TGF-beta family members as novel therapeutic targets for endocrine, metabolic and immune disorders.
    Tsuchida K
    Curr Drug Targets Immune Endocr Metabol Disord; 2004 Jun; 4(2):157-66. PubMed ID: 15180456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of Activin Receptor Type IIA and its expression during gonadal maturation and growth stages in rohu carp.
    Patnaik S; Mohanty M; Bit A; Sahoo L; Das S; Jayasankar P; Das P
    Comp Biochem Physiol B Biochem Mol Biol; 2017 Jan; 203():1-10. PubMed ID: 27575753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy.
    Liu M; Hammers DW; Barton ER; Sweeney HL
    PLoS One; 2016; 11(11):e0166803. PubMed ID: 27870893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of muscle growth by multiple ligands signaling through activin type II receptors.
    Lee SJ; Reed LA; Davies MV; Girgenrath S; Goad ME; Tomkinson KN; Wright JF; Barker C; Ehrmantraut G; Holmstrom J; Trowell B; Gertz B; Jiang MS; Sebald SM; Matzuk M; Li E; Liang LF; Quattlebaum E; Stotish RL; Wolfman NM
    Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18117-22. PubMed ID: 16330774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two Activin Type 2B Receptors from Sea Bream Function Similarly in vitro.
    Nadjar-Boger E; Krol E; Funkenstein B
    Biol Bull; 2016 Feb; 230(1):56-67. PubMed ID: 26896178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle growth in teleost fish is regulated by factors utilizing the activin II B receptor.
    Phelps MP; Jaffe IM; Bradley TM
    J Exp Biol; 2013 Oct; 216(Pt 19):3742-50. PubMed ID: 23788712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunolocalization of type I or type II activin receptors in the rat brain.
    Funaba M; Murata T; Fujimura H; Murata E; Abe M; Torii K
    J Neuroendocrinol; 1997 Feb; 9(2):105-11. PubMed ID: 9041363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin type IIB receptor blockade does not limit adenosine triphosphate supply in mouse skeletal muscle in Vivo.
    Béchir N; Pecchi É; Vilmen C; Bernard M; Bendahan D; Giannesini B
    Muscle Nerve; 2018 Dec; 58(6):834-842. PubMed ID: 30025155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small molecules dorsomorphin and LDN-193189 inhibit myostatin/GDF8 signaling and promote functional myoblast differentiation.
    Horbelt D; Boergermann JH; Chaikuad A; Alfano I; Williams E; Lukonin I; Timmel T; Bullock AN; Knaus P
    J Biol Chem; 2015 Feb; 290(6):3390-404. PubMed ID: 25368322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing for the erythropoiesis-stimulating agent Sotatercept/ACE-011 (ActRIIA-Fc) in serum by means of Western blotting and LC-HRMS.
    Walpurgis K; Thomas A; Vogel M; Reichel C; Geyer H; Schänzer W; Thevis M
    Drug Test Anal; 2016 Nov; 8(11-12):1152-1161. PubMed ID: 27649383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The activin receptor ligand trap ActRIIB:ALK4-Fc ameliorates cardiomyopathy induced by neuromuscular disease and diabetes.
    Li J; Fredericks M; Tang M; Cannell M; Joshi S; Kumar R; Andre P; Suragani RNVS
    FEBS Lett; 2022 Dec; 596(24):3145-3158. PubMed ID: 35920165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.